Trump's Plan to Cut Drug Prices Was to Buy From Canada. Canada Said No.

Americans pay up to ten times more for insulin than Canadians living minutes across the border — and Donald Trump's signature plan to lower U.S. drug prices depends entirely on importing from, or matching the prices of, the very country he keeps tariffing. There's just one problem: Canada already said no. In this episode, James Wren breaks down why U.S. drug prices are the highest on Earth, how Canada's price regulation made the same medicine a fraction of the cost, why Trump's two-door plan (import from Canada / Most-Favored-Nation pricing) runs into a wall Canada built on purpose — and the honest case on every side, including why the real fix was always at home. 🤖 This video was created with AI assistance — AI-generated voice, AI-assisted research and writing. Real sources, real analysis. Sources include: RAND Corporation / U.S. HHS, Mayo Clinic Proceedings, the Patented Medicine Prices Review Board, Health Canada (Safeguarding the Drug Supply regulations), the FDA, and U.S. Congressional Research Service. #DrugPrices #Insulin #Canada #Trump #Tariffs #Pharma #HealthCare